Trending in Australia: Oncology, Industry, and Monoclonal Antibodies Dominate 2012 – 2016 Clinical Trials

Trending in Australia: Oncology, Industry, and Monoclonal Antibodies Dominate 2012 – 2016 Clinical Trials

09:31, October 9 2017

By GlobalData

Brooke Wilson & Marco Borria, GlobalData, describe the clinical trial landscape in Australia

Download Whitepaper

Trending in Australia: Oncology, Industry, and Monoclonal Antibodies Dominate 2012 – 2016 Clinical Trials
More Whitepapers